International scientific cooperation
Development of drugs is an exciting journey of creativity and scientific research aimed at achieving a higher goal – the creation of a healthy future.
GEROPHARM is always striving to use the best knowledge, relying on the team of professionals who have experience of working abroad in the largest multinational pharmaceutical companies.
Research interests in the development of innovative drugs links company with leading laboratories and research centers in Russia and abroad.
Among them Moscow state University. M. V. Lomonosov Moscow state University, Military medical Academy n. a. S. M. Kirov, First Saint Petersburg state medical University. Acad. I. P. Pavlov, Institute of pharmacology, Tomsk scientific center SB RAMS, Institute of molecular genetics of RAS, state scientific centre of children Health RAMS (research Institute of Pediatrics), DIRECTOR of the Institute of Higher Nervous Activity and neurophysiology of RAS, Institute of the human brain. N. P. Bekhtereva Russian Academy of Sciences, Institute of Pharmacology named after V. V. nine RAMS, Institute of physiology n. a. I. P. Pavlov of the Russian Academy of Sciences, the European Mind and Metabolism Association (EMMA), National Institute of Health (Rome, Italy), Monash University (Melbourne, Australia), Emory University (Atlanta, GA, USA), Shin Nippon Biomedical Laboratories (Kagoshima, Japan), Turku Science Park Ltd (Turku, Finland), Charles River (Kuopio, Finland), MikroKemi pharma laboratories (Uppsala, Sweden).
GEROPHARM Group actively shares its expertise on the main issues of market regulation through participating in major international conferences and congresses. It also attracts foreign experts from the EMEA and FDA to take part in those events which enables development of a competent and balanced approach to new trends in the pharmaceutical industry, for example, to the development of biologics (biosimilars).